Analyst Recommendations

BTIG analyst issues BUY recommendation for MGNX on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.MGNX was trading at $19.06 at issue of the analyst...

March 4, 2024   MGNX -2.92%

Wedbush analyst issues BUY recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 0.48%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 0.48%

Wells Fargo analyst issues OVERWEIGHT recommendation for CRWD on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.CRWD was trading at $314.6 at issue of the...

March 4, 2024   CRWD 1.25%

Cowen & Co. analyst issues NEUTRAL recommendation for QURE on March 4, 2024 07:56AM ET. The previous analyst recommendation was Neutral.QURE was trading at $5.59 at issue of...

March 4, 2024   QURE -2.70%

Needham analyst issues BUY recommendation for RXRX on March 4, 2024 08:02AM ET. The previous analyst recommendation was Buy.RXRX was trading at $12.81 at issue of the analyst...

March 4, 2024   RXRX 4.71%

Cowen & Co. analyst issues OUTPERFORM recommendation for MTZ on March 4, 2024 07:56AM ET. The previous analyst recommendation was Outperform.MTZ was trading at $84.85 at issue of...

March 4, 2024   MTZ 0.65%

Telsey Advisory analyst issues MARKET PERFORM recommendation for OLPX on March 4, 2024 09:01AM ET. The previous analyst recommendation was Market Perform.OLPX was trading at $1.82 at issue...

March 4, 2024   OLPX -1.09%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 0.48%

Wells Fargo analyst issues BUY recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.COST was trading at $749.44 at issue of the...

March 4, 2024   COST -0.36%